These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 2228237)

  • 1. Engineering of genetically detoxified pertussis toxin analogs for development of a recombinant whooping cough vaccine.
    Loosmore SM; Zealey GR; Boux HA; Cockle SA; Radika K; Fahim RE; Zobrist GJ; Yacoob RK; Chong PC; Yao FL
    Infect Immun; 1990 Nov; 58(11):3653-62. PubMed ID: 2228237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of pertussis toxin analogs containing mutations in B-oligomer subunits.
    Loosmore S; Zealey G; Cockle S; Boux H; Chong P; Yacoob R; Klein M
    Infect Immun; 1993 Jun; 61(6):2316-24. PubMed ID: 8500874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction of Bordetella pertussis strains that overproduce genetically inactivated pertussis toxin.
    Zealey GR; Loosmore SM; Yacoob RK; Cockle SA; Herbert AB; Miller LD; Mackay NJ; Klein MH
    Appl Environ Microbiol; 1992 Jan; 58(1):208-14. PubMed ID: 1539974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutants of pertussis toxin suitable for vaccine development.
    Pizza M; Covacci A; Bartoloni A; Perugini M; Nencioni L; De Magistris MT; Villa L; Nucci D; Manetti R; Bugnoli M
    Science; 1989 Oct; 246(4929):497-500. PubMed ID: 2683073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction of Bordetella pertussis strains with enhanced production of genetically-inactivated Pertussis Toxin and Pertactin by unmarked allelic exchange.
    Buasri W; Impoolsup A; Boonchird C; Luengchaichawange A; Prompiboon P; Petre J; Panbangred W
    BMC Microbiol; 2012 Apr; 12():61. PubMed ID: 22524455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction and characterization of genetically inactivated pertussis toxin.
    Brown DR; Keith JM; Sato H; Sato Y
    Dev Biol Stand; 1991; 73():63-73. PubMed ID: 1778335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pertussis toxin S1 mutant with reduced enzyme activity and a conserved protective epitope.
    Burnette WN; Cieplak W; Mar VL; Kaljot KT; Sato H; Keith JM
    Science; 1988 Oct; 242(4875):72-4. PubMed ID: 2459776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress towards the development of new vaccines against whooping cough.
    Rappuoli R; Podda A; Pizza M; Covacci A; Bartoloni A; de Magistris MT; Nencioni L
    Vaccine; 1992; 10(14):1027-32. PubMed ID: 1471424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene replacement in Bordetella pertussis by transformation with linear DNA.
    Zealey GR; Loosmore SM; Yacoob RK; Cockle SA; Boux LJ; Miller LD; Klein MH
    Biotechnology (N Y); 1990 Nov; 8(11):1025-9. PubMed ID: 1366929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective immunogenicity of synthetic peptides selected from the amino acid sequence of Bordetella pertussis toxin subunit S1.
    Askelöf P; Rodmalm K; Wrangsell G; Larsson U; Svenson SB; Cowell JL; Undén A; Bartfai T
    Dev Biol Stand; 1991; 73():111-20. PubMed ID: 1778305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineering bacterial toxin for the development of new vaccine against pertussis.
    Bartoloni A; Pizza M; Gross R; Perugini M; Arico B; Domenighini M; Rappuoli R
    Tokai J Exp Clin Med; 1988; 13 Suppl():217-22. PubMed ID: 2483870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant acellular pertussis vaccine--from the laboratory to the clinic: improving the quality of the immune response.
    Rappuoli R; Pizza M; Covacci A; Bartoloni A; Nencioni L; Podda A; De Magistris MT
    FEMS Microbiol Immunol; 1992 Oct; 5(4):161-70. PubMed ID: 1384602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of a synthetic pertussis toxin operon in Escherichia coli.
    Pozza TD; Yan H; Walker MJ
    Vaccine; 1997 Jun; 15(9):968-75. PubMed ID: 9261943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stable expression of pertussis toxin in Bordetella bronchiseptica under the control of a tightly regulated promoter.
    Suarez A; Staendner LH; Rohde M; Piatti G; Timmis KN; Guzmán CA
    Appl Environ Microbiol; 1997 Jan; 63(1):122-7. PubMed ID: 8979346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant Mycobacterium bovis BCG expressing pertussis toxin subunit S1 induces protection against an intracerebral challenge with live Bordetella pertussis in mice.
    Nascimento IP; Dias WO; Mazzantini RP; Miyaji EN; Gamberini M; Quintilio W; Gebara VC; Cardoso DF; Ho PL; Raw I; Winter N; Gicquel B; Rappuoli R; Leite LC
    Infect Immun; 2000 Sep; 68(9):4877-83. PubMed ID: 10948100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of genetically inactivated pertussis toxin mutants: candidates for a new vaccine against whooping cough.
    Nencioni L; Pizza M; Bugnoli M; De Magistris T; Di Tommaso A; Giovannoni F; Manetti R; Marsili I; Matteucci G; Nucci D
    Infect Immun; 1990 May; 58(5):1308-15. PubMed ID: 2323818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cellular and acellular anti-pertussis vaccines].
    Locht C
    Ann Pharm Fr; 2001 May; 59(3):198-205. PubMed ID: 11427821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction of minitransposons for constitutive and inducible expression of pertussis toxin in bvg-negative Bordetella bronchiseptica.
    Walker MJ; Rohde M; Wehland J; Timmis KN
    Infect Immun; 1991 Nov; 59(11):4238-48. PubMed ID: 1682257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of mutant strains producing pertussis toxin cross reacting materials.
    Sato Y; Sato H; Chazono M; Ginnaga A; Tamura C
    Dev Biol Stand; 1991; 73():93-107. PubMed ID: 1778339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acellular pertussis vaccine composed of genetically inactivated pertussis toxin.
    Peppoloni S; Pizza M; De Magistris MT; Bartoloni A; Rappuoli R
    Physiol Chem Phys Med NMR; 1995; 27(4):355-61. PubMed ID: 8768791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.